Early phase combined therapeutic management of acute ischaemic stroke

Pietro Bassi, P. Lattuada, S. Tonietti

Research output: Contribution to journalArticlepeer-review


An adequate treatment of ischaemic stroke in the early phase (28-48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.

Original languageEnglish
JournalNeurological Sciences
Issue numberSUPPL. 1
Publication statusPublished - May 2005


  • Acute phase
  • Cerebral ischaemia
  • Stroke unit
  • Treatment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology


Dive into the research topics of 'Early phase combined therapeutic management of acute ischaemic stroke'. Together they form a unique fingerprint.

Cite this